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Introduction
Endometrial cancer (EC) is the most common gynecological malignancy in the industrialized world and can be classified into two different clinicopathological types, estrogen-related ECs (type I) and non-estrogen-related ECs (type II). The most frequent genetic alteration in type I ECs is PTEN inactivation, followed by microsatellite instability and mutations of the KRAS and β-catenin. In type II ECs, TP53 mutation is the most frequent genetic alteration, followed by amplification of ERBB2 (1) . Some of these pathways are important determinants of stem cell activity (Wnt-β-catenin and PTEN) (2) (3) (4) . These findings suggest a stem cell contribution to endometrial carcinoma development.
Recent evidence suggests that cancer stem-like cells exist in several malignant tumors, such as leukemia (5, 6) , breast cancer (7) and brain tumors (8) , and that these stem cells express surface markers similar to those expressed by normal stem cells in each tissue (5, 9) . Stem cell subpopulations ("side-population" [SP] cells) have been identified in many mammals, including humans, based on the ability of these cells to efflux the fluorescent dye Hoechst 33342 (10) . The SP phenotype is associated with a high expression level of the ATP-binding cassette transporter protein ABCG2/ Bcrp1 (11) . Established malignant cell lines, which have been maintained for many years in culture, have also been shown to contain SP cells as a minor subpopulation (12) . Friel et al. showed that SP cells derived from the endometrial cancer cell lines properties (14) . Gotte et al. demonstrated that the adult stem cell marker, Musashi-1 was co-expressed with Notch-1 in a subpopulation of endometrial cells (15) . Furthermore, they showed that telomerase and Musashi-1 expressing cells were significantly increased in proliferative endometrium, endometriosis and endometrial carcinoma tissue, compared to secretary endometrium, suggesting the concept of a stem cell origin of endometriosis and endometrial carcinoma. Most recently, they demonstrated that siRNA depletion of Musashi-1, an adult stem cell marker enriched in the SP, in the endometrial carcinoma cell line Ishikawa leads to interference with the Notch signaling pathway and p21 expression, resulting in an antiproliferative effect and induction of apoptosis (16) .
The regulation of histone acetylation is a major mechanism controlling cellular differentiation and the biological phenotype of cancer cells (17) . Histone deacetylases (HDACs) and histone acetyl transferases are enzymes that ensure the homeostatic levels of histone acetylation. Deregulated HDAC activity has been found in certain human cancers (18) (19) (20) (21) (22) . Several studies have demonstrated the antiproliferative or the proapoptotic effects of HDAC inhibitors on endometrial cancer cells (23) (24) (25) . Thus, HDACs are important therapeutic targets for cancer and several HDAC inhibitors are in various stages of clinical development (26, 27) . However, the effect of HDAC inhibitors on proliferation of cancer stem cells is unknown.
We have isolated SP cells from normal human endometrium and from a human endometrial cancer cell-line, Hec1, and characterized their properties (28, 29 Cells used were always less than 20 passages.
Isolation of SP cells
To identify and isolate Hec1 and RK12 V SP cells, the cells were dislodged from the culture dishes with trypsin and EDTA, washed, and suspended at a concentration of 10 (Iwaki, Funabashi, Japan). The cells were cultured for two to four weeks. The cells were then transferred to collagen-coated 60 mm plates.
Growth rate assay
Cells were plated in a MF-medium in the presence or absence of NaB (Sigma-Aldrich, Japan). Cell viability was determined using trypan blue exclusion assay. Floating cells were washed away and the cells were detached from dishes by 0.25% trypsin. Collected cells were stained with 0.4% trypan blue and were counted using hematocytometer. 
Self-Renewal assays

Soft agar assays
For the anchorage-independent growth assays in soft agar, 1X10 4 cells were seeded in 60 mm dishes containing growth medium, supplemented with 10% FBS and 0.3%
Bactoagar over a hardened 0.5% agar base layer in the presence or absence of 2 or 5 mM NaB. Cells were incubated for three weeks and the number of colonies per 4cm 2 was counted under a microscope.
In vivo tumor formation assays
We inoculated 1X10 In vitro sensitivity to chemotherapeutic agents RK12V-SP cells and -NSP cells were cultured for 96 hr in the presence or absence of 1μM cisplatin, 1μM doxorubicin, or 10nM paclitaxel. Viable cells determined by the trypan blue exclusion assay were counted using a hemocytometer.
Cell cycle analysis
The DNA content of cells was measured by flow cytometric analysis (EPICSXL, Beckman Coulter) using the propidium iodide (PI) staining method. Cells ( 
Immunohistochemistry
Formalin-fixed histological tumor sections from nude mice or cultured cells were used.
Cultured cells were incubated on glass chamber slides (LAB-TEK; Nalge Nunc International Corp. Naperville, USA) and fixed by treatment with 10% formalin.
Sections were rinsed twice in phosphate buffered saline (PBS, pH 7.4) for five min each. Samples were then incubated with 4% blocking horse serum (Vector Laboratories, Burlingame, USA) for one hr at room temperature in a humidified chamber, followed by incubation with the primary antibody (200 μg/mL, 1:100 diluted). We also used nonimmune mouse or rabbit IgG as a control for the primary antibody. Staining with the primary or control antibody was performed overnight at 4 °C. Bound antibodies were detected with a biotinylated anti-rabbit IgG secondary antibody (1.5mg/ml) and an avidin-biotin complex linked to horseradish peroxidase (Vectastain, Vector Laboratories, Burlingame, USA), followed by incubation with diaminobenzidine tetrahydrochloride as the substrate. Osaka, Japan). 
Analysis of γH2AX foci
Cells were incubated on glass chamber slides (LAB-TEK; Nalge Nunc International Corp. Naperville, USA) in the presence or absence of 5 mM NaB for 24hr and cells were fixed by treatment with 10% formalin. γH2AX foci were analyzed by immunohistochemstry using phospho-histone 2AX (Ser139) antibody. γH2AX were counted visually by microscopy, examining ten cells in three different areas of the slide per each condition. Three independent experiments were performed.
Western blotting
To detect each protein expression, subconfluent cells were lysed with ice-cold lysis buffer (20mM Tris HCl, pH8.0, 1% Triton X-100, 10% glycerol, 137mM NaCl,1.5mM MgCl 2 , 1mM EGTA, 50mM NaF, 1mM Na 3 VO 4 ) containing freshly added protease inhibitors (1mM phenyl methyl sulphonylfluoride, 1μg/mL leupeptin, and 10μg/mL aprotinin) (Sigma, St Louis, USA). After centrifugation at 13,000 X g for ten min to remove debris, 10μg of the proteins were subjected to SDS-PAGE and transferred onto a nitrocellulose membrane in a semi-dry transfer cell (Bio Rad Laboratories, Hercules, USA). The blots were incubated with diluted primary antibodies overnight at 4°C. Primary antibodies, including the anti-CD13 polyclonal antibody, anti-E-cadherin polyclonal antibody, and anti-vimentin polyclonal antibody were obtained from Santa Cruz Biotechnology, Inc., USA. After incubation with each primary antibody (1:1000 diluted), the blots were incubated with horseradish peroxidase-linked anti-rabbit antibodies and analysed with an ECL system (Amersham Bioscience, Buckinghamshire, UK). The levels of protein expression were quantitated using Image J software.
Microdissection and DNA extraction
Glass slides with an overlay of 4 mm of thin LM Film (PALM Microlaser Technologies GmbH,Bernried,Germany) were prepared. Formalin-fixed, paraffinembedded tumor tissue was cut into seven μm sections and placed on the slides. The sections were then deparaffinized and stained with hematoxylin and eosin. Using a laser microdissection system (Leica Microsystems, Germany), tumor cells, or stromal cells were isolated into the cap of a 0.5 mL microtube. After retrieval of the cells, 50 μL proteinase K solution (Pico Pure DNA Extraction kit)(ARCTURUS, CA, USA) was added into the cap. The DNA was extracted by overnight incubation at 65 °C. The solution was then boiled for ten min to inactivate the proteinase K.
Polymerase Chain Reaction (PCR) of the KRAS gene
To amplify the KRAS gene (cDNA for RK12V-SP tumor), polymerase chain reaction (PCR) using a T3000 thermal cycler was performed (Biometra). The primers used for PCR were as follows: 5'-GACTGAATATAAACTT-3'(sense); 5'- 
Determination of the KRAS sequence
PCR products were electrophoresed on a 2% agarose gel and the band corresponding to the desired target cut from the gel. DNA was extracted using the GFX PCR DNA gel band purification kit (GE Healthcare , UK). Direct sequencing of the PCR product was then performed using an ABI PRISM Big Dye Termination Ver3.1 Cycle Sequencing Kit according to the manufacturer's instructions and the ABI PRISM 3100 (Applied Biosystems, CA, USA). The primer used for sequencing was as follows:
5'-TTGAAACCCAAGGTACATTTCA-3'(antisense) for KRAS DNA.
Data analysis
Data are represented with the means ± SEM and were analyzed with Student's t-test. A P-value of less than 0.05 was considered statistically significant. 
Results
RK12V-SP cells show features of cancer stem-like cells.
First of all, we analyzed K12V-SP cells' self-renewal capacity and potential to develop into stromal cells. When RK12V-SP cells were plated in collagen-coated dishes (10 cells/cm 2 ), they proliferated and formed large (>2mm) colonies. In contrast, RK12V-NSP cells formed only small colonies (Fig. 1A) . We tested their self-renewal 
RK12V-SP cells display higher resistance to conventional chemotherapeutic drugs.
Next, we investigated the effect of cisplatin, paclitaxel and doxorubicin (clinically used for endometrial cancer chemotherapy) on the proliferation of RK12V-SP cells and -NSP cells (Fig.3) . Ninety-six hr incubation of RK12V-NSP cells with medium containing these chemotherapeutic drugs inhibited proliferation compared with control.
Relative to control, the extent of inhibition was 61% in 1μM cisplatin, 51% in10nM paclitaxel and 56% in 1μM doxorubicin. All of these drugs inhibited the proliferation of RK12V-NSP cells significantly compared with control (p<0.001). In contrast, none of these drugs had an inhibitory effect on the growth of RK12V-SP cells.
Treatment of NaB inhibits self-renewal capacity of RK12V-SP cells.
We previously demonstrated that 2mM NaB, a short-chain fatty acid HDAC inhibitor, induced senescence and apoptosis in several types of gynecologic cancer (34). Takai Based on these previous data, we examined the effect of 2 or 5 mM NaB on cell proliferation of both RK12V-SP cells and -NSP cells.
We first confirmed by Western blot that the levels of acetylated H3 were enhanced in both RK12V-SP cells and -NSP cells treated with 2 mM NaB for 72 hr compared with that in untreated cells (Fig. 4A ).
Treatment with 2 or 5mM NaB for 96 hr significantly inhibited cell proliferation of RK12V-SP cells as well as RK12V-NSP cells (Fig.4B, p<0 p<0.01; n = 4, Fig. 4C a) . The primary colony-forming potential of RK12V-SP cells was completely suppressed by treatment by 2 mM NaB (Fig. 4C b) .
Next, we analyzed the cell cycle alteration in response to NaB using flow cytometry with propidium iodide (PI) staining. Treatment with NaB for 24 hr resulted in a significant decrease in the fraction of RK12V-SP cells in S phase in a dose-dependent manner (control, 22.5%; 2 mM NaB, 14%; 5 mM NaB, 10%; p<0.05) (Fig.4D) .
Conversely, the percentages of cells in a sub-G1 population increased, but it was not statistically significant. In RK12V-NSP cells, there was no significant change in the cell cycle phase distribution.
NaB treatment suppresses colony formation of RK12V-SP cells in soft agar cultures.
Next, we investigated the effect of NaB treatment on tumorigenicity of RK12V-SP cells and -NSP cells by evaluating colony forming efficiency in soft agar cultures in the presence or absence of 2 or 5 mM NaB. After three weeks of culture, RK12V-SP cells yielded many large colonies in the control culture lacking NaB (Fig. 5) The levels of intracellular ROS were enhanced by 5 mM NaB treatment in both RK12V-SP cells and -NSP cells (Fig.6 A) . Phosphorylated H2AX (γH2AX) foci, which are indicators of DNA damage, were assessed by immunohistochemistry. The numbers of γH2AX foci were increased by 5mM NaB treatment in both RK12V-SP cells and -NSP cells (Fig.6 B) . The levels of γH2AX proteins were markedly increased in RK12V-SP cells (44-fold) compared with that in RK12V-NSP cells (2-fold) (Fig.6C) . The p21, p27, and phospho-p38 MAPK expression levels were also enhanced more in RK12V-SP cells than in RK12V-NSP cells. These results imply that treatment with NaB induced production of intracellular ROS and DNA damage in both RK12V-SP and -NSP cells. 
HDAC inhibitors have multiple biological effects, including growth arrest, apoptosis, senescence, reactive oxygen-species facilitated cell death, mitotic cell death and anti-angiogenesis (17) . HDAC inhibitors include short-chain fatty acids (e.g. butyrates and VPA), organic hydroxamic acids (TSA and suberoyl anilide bishydroxamine[SAHA]),cyclic tetra peptides (e.g. Trapoxin), and bezamides (e.g. MS-275) . TSA, NaB, VPA and SAHA can inhibit malignant cells in vitro and in vivo (37) (38) (39) . We have previously demonstrated that NaB induced p21 expression, resulting in growth arrest and cell death (34) . Recently, we have also shown that DNA damage signals were involved in NaB-induced cell death (35). In this study, NaB inhibited (40) . They also found γH2AX could be used as a convenient pharmacodynamic biomarker for HDAC inhibitors-induced DNA damage (41) . We demonstrated that γH2AX was markedly enhanced in RK12V-SP cells compared with that in RK12V-NSP cells, implying that RK12V-SP cells were highly sensitive to NaB-induced DNAdamage (Fig. 6) . These results indicated that cancer stem-like cells, which are resistant to conventional chemotherapy, were sensitive to treatment with HDAC inhibitors. It is 
